Joel Greenblatt - Gotham Asset Management
Holding/activity history for Pdl Biopharma Inc (PDLI)
← All PDLI superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2017 Q1 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2016 Q4 | 29,531 | <0.01 | Reduce 97.67% | 0.06 | $2.13 | $63,000 | SEC |
| 2016 Q3 | 1,266,121 | 0.06 | Reduce 44.80% | 0.04 | $3.35 | $4,242,000 | SEC |
| 2016 Q2 | 2,293,523 | 0.09 | Reduce 38.56% | 0.05 | $3.14 | $7,202,000 | SEC |
| 2016 Q1 | 3,732,679 | 0.14 | Reduce 21.40% | 0.04 | $3.33 | $12,430,000 | SEC |
| 2015 Q4 | 4,748,690 | 0.19 | Reduce 5.90% | 0.02 | $3.54 | $16,810,000 | SEC |
| 2015 Q3 | 5,046,353 | 0.26 | Reduce 30.24% | 0.12 | $5.03 | $25,383,000 | SEC |
| 2015 Q2 | 7,233,838 | 0.40 | Add 114.94% | 0.22 | $6.43 | $46,514,000 | SEC |
| 2015 Q1 | 3,365,474 | 0.19 | Add 1739.03% | 0.18 | $7.03 | $23,676,000 | SEC |
| 2014 Q4 | 183,003 | 0.01 | Add 603.94% | 0.01 | $7.71 | $1,411,000 | SEC |
| 2014 Q3 | 25,997 | <0.01 | Reduce 96.71% | 0.10 | $7.46 | $194,000 | SEC |
| 2014 Q2 | 789,804 | 0.10 | Reduce 52.58% | 0.12 | $9.68 | $7,645,000 | SEC |
| 2014 Q1 | 1,665,543 | 0.22 | Reduce 50.19% | 0.36 | $8.31 | $13,841,000 | SEC |
| 2013 Q4 | 3,343,973 | 0.71 | Add 15.69% | 0.10 | $8.44 | $28,223,000 | SEC |
| 2013 Q3 | 2,890,564 | 0.79 | Add 24.84% | 0.16 | $7.97 | $23,038,000 | SEC |
| 2013 Q2 | 2,315,381 | 0.81 | Add 8.43% | 0.06 | $7.72 | $17,875,000 | SEC |
| 2013 Q1 | 2,135,460 | 0.85 | Add 23.50% | 0.16 | $7.30 | $15,589,000 | SEC |
| 2012 Q4 | 1,729,133 | 0.76 | Add 561.89% | 0.65 | $7.04 | $12,173,000 | SEC |
| 2012 Q3 | 261,241 | 0.15 | Reduce 7.86% | 0.01 | $7.70 | $2,012,000 | SEC |
| 2012 Q2 | 283,532 | 0.15 | Add 4.88% | <0.01 | $6.63 | $1,880,000 | SEC |
| 2012 Q1 | 270,346 | 0.16 | Add 33.54% | 0.04 | $6.36 | $1,719,000 | SEC |
| 2011 Q4 | 202,444 | 0.16 | Add 31.29% | 0.04 | $6.20 | $1,255,000 | SEC |
| 2011 Q3 | 154,201 | 0.15 | Add 41.81% | 0.04 | $5.55 | $856,000 | SEC |
| 2011 Q2 | 108,735 | 0.10 | Reduce 14.29% | 0.03 | $5.87 | $638,000 | SEC |
| 2011 Q1 | 126,863 | 0.24 | Add 128.09% | 0.14 | $5.80 | $736,000 | SEC |
| 2010 Q4 | 55,620 | 0.13 | $6.24 | $347,000 | SEC |